Socio-economic factors and outcomes in chronic lung disease of prematurity

Keyphrases

• Socioeconomic Factors 100%
• Respiratory Morbidity 100%
• Chronic Lung Disease of Prematurity 100%
• Risk Factors 50%
• Health Disparities 50%
• Systemic Steroids 50%
• Non-white 50%
• Respiratory Symptoms 50%
• Therapy Decision 50%
• Increased Activity 25%
• Hospitalization 25%
• Etiology 25%
• Socioeconomic Status 25%
• White People 25%
• Race-ethnicity 25%
• Gestational Age 25%
• Non-associated 25%
• Length of Stay 25%
• Regression Model 25%
• Public Health Insurance 25%
• 3-year-olds 25%
• Decreased Risk 25%
• Morbidity Data 25%
• Gastrostomy Tube 25%
• Clinic Visits 25%
• Insurance Coverage 25%
• Median Income 25%
• Neonatal Intensive Care Unit 25%
• Steroid Use 25%
• Treatment Parameters 25%
• Supplemental Oxygen 25%
• Rescue Medication 25%
• Rescue Medication Use 25%
• Inhaled Corticosteroid Therapy 25%
• Activity Limitations 25%
• Initial Spacing 25%
• Respiratory Treatment 25%
• Tube Length 25%

Medicine and Dentistry

• Prematurity 100%
• Chronic Lung Disease 100%
• Respiratory System Disease 100%
• Drug Therapy 50%
• Symptom 50%
• Emergency Medical Technician 50%
• Gestational Age 25%
• Pregnancy 25%
• Socioeconomic Status 25%
• Gastrostomy 25%
• Household 25%
• Neonatal Intensive Care Unit 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Prematurity 100%
• Chronic Lung Disease 100%
• Symptom 50%